Investors Hub Daily
|
Home
|
Log in
Boards
Stocks
Commodities
Forex
The Lounge
Hot!
Breakout Boards
iHub My Stocks Activity
Ticker Buzz Cloud
Top Boards
Most Read
Most Posted
Most Followed Members
Recent News
Active Boards
Site Stats
New Boards
Hot on StockWiki
Data Tools
Charts
Trader Alerts
Trades
Portfolio
Top Lists
News Alerts
Commodities
More Tools
My Image Gallery
Advanced Search
Videos
All News
Stock Screener
News Filter
Live Charts
Live News
Live Desktop
Forex Prices
Commodities
ETF Center
Online Brokers
Educational Channel
Streamer
Level 2
Home
>
Boards
>
US OTC
>
Biotechs
>
NuPathe (PATH)
Again, my guess is that PATH had a
Public Reply
|
Private Reply
|
Keep
|
Last Read
Post New Msg
Replies (1)
|
Next 10
|
Previous
|
Next
surf1944
Monday, August 29, 2011 10:16:21 PM
Re:
surf1944
post# 144
Post #
of
642
Again, my guess is that PATH had a
no
from the FDA review. Maybe they are trying to get more detail from the FDA, but they will almost have to release what came from the FDA prior to pre-market trading or the company will come up against other issues. Unless they continue the halt.
http://www.nasdaqtrader.com/Trader.aspx?id=Tradehalts
T1 Halt - News Pending
Trading is halted pending the release of material news.
surf's up......crikey
NuPathe (PATH) Stock Trading Info:
Public Reply
|
Private Reply
|
Keep
|
Last Read
Post New Msg
Replies (1)
|
Next 10
|
Previous
|
Next
Follow Board
Keyboard Shortcuts
Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote
-
Discussion Board
+/- to Watchlist
© 2013 InvestorsHub.Com, Inc.